Friday, June 22, 2018

Annalisa Trama

MD, Epidemiologist, National Cancer Institute, Milan, Italy

Annalisa Trama
Annalisa Trama

Dr. Annalisa Trama graduated cum laude in Medicine and Surgery from the University of Rome "La Sapienza"(1993-1999). She obtained her Master’s in health services/system research from London School of Hygiene and Tropical Medicine (2001-2002), she specialized in Public Health from University “La Sapienza”– Rome (1999-2003). She obtained her PhD in Public Health from University “La Sapienza”– Rome (2004-2006).

Work Experience:
From 05/2009 until Today:
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano – evaluative epidemiology unit (medical director). Research activities on rare cancers: descriptive epidemiology of rare cancers, defintion of criteria for centres of expertise on rare cancers, study on the patterns of care of rare cancers, evalaution of prognostic factors in mesothelioma long-term survivors, coordination with scientific societies, patients associations, and relevant international projects on cancers. Research activities on children and on adolescent and young adults cancers (AYA): descriptive epidemiology and patterns of care study, collaboration with the Division of Cancer Control and Population Sciences (DCCPS), National Cancer Institute, Surveillance Research Program (SRP), Surveillance, Epidemiology and End Results (SEER) for the revision of the AYA classification.

Patterns of care study on prostate cancer. EUROCARE (European cancer registries based study of cancer patients survival and care): coordination team and quality checks, Collaboration with START (State of the art of oncology in Europe http://www.startoncology.net). Project assistant of RARECARE (Surveillance of rare cancers in Europe); RARECAREnet (information network on rare cancers), RITA (Surveillance of rare cancers in Italy), RITA2 (Rare Cancers in ltaly: Surveillance and evaluation of the access to diagnosis and treatment), LUME (Mesothelioma survivors in Italy: what is contributing to long term survival?), JARC (Joint Action on Rare Cancers) Section editor (epidemiology area) of Tumori Journal, Reviewers of several epidemiological scientific journal

From 09/2006 until 04/200:
Italian National Institute of Health –National Centre for Rare Diseases Rome, Italy
Research activities on rare diseases and orphan drugs including: development of a post marketing surveillance system for orphan drugs in Italy and involvement in several European projects.

From 01/ 2004 until 09/ 2006:
United Nation Programme on HIV and AIDS (UNAIDS), Kenya. Program officer of UNAIDS. Involved in the development of the United Nations Implementation Support Plans for country response to HIV and AIDS and in the development of the national HIV and AIDS monitoring system.

© 2018 Boussias Communications, all rights reserved. info@boussias.com, T:210 6617777, F:210 6617778

Designed by Boussias
New Media Team